You are here

research

Biocat BioRegion abril 2018
24.04.2018

This month, researchers in the BioRegion have published articles in the highest impact science journals, while pharmaceutical and biotechnology companies have advanced their growth plans and drugs

ERC Advanced Grants Catalunya Biocat
18.04.2018

Projects from ICFO, IRB Barcelona and ISGlobal have been selected in the latest round of ERC Advanced Grants. Catalonia has been awarded 3.6% of these grants in the life sciences, surpassing countries like Belgium and the Netherlands.

BioRegio Març 2018
26.03.2018

New rounds of crowdfunding, patents, trade agreements and scientific publications round out the headlines for March in the BioRegion

CRAASH Barcelona able exoesquelet
23.03.2018

35 projects, 70% from the BioRegion, applied to the acceleration program promoted by Biocat and CIMIT (Boston)

wild card biocat eit health
12.03.2018

The finalists will face off from April 16 to 20 in Galway in a tournament to choose the members of two teams that will receive €2 million each

Aceleradora enfermedades raras AMMIC RIS3CAT Biocat
05.03.2018

Acceleradora en Malalties Minoritàries de Catalunya (AMMIC) is part of the RIS3CAT community coordinated by Biocat. It is led by IUCT and other members include VHIR, Esteve, Aromics, BCN Peptides, Minoryx, Aniling and Qgenomics

BioRegio Catalunya febrer 2018
26.02.2018

Firm led by Jordi Carrera hits archetypal milestone for sector amidst effervescent month of February

BioRegion wrapup
26.01.2018

2018 has kicked off with a month full of headlines regarding business operations and scientific publications 

BioRegion2017_lessonslearned
29.01.2018

Publications in top journals, rounds of investment, licensing, benchmark events held in Barcelona... 2017 was a year full of good news for the BioRegion of Catalonia. Saying goodbye to the EMA and the political instability were the bittersweet counterpoint. What can we learn from these successes and failures? From research, enterprise and management, some of the main figures take stock. 

BIO Europe Spring 2017
20.12.2017

Cutting-edge studies in the best international scientific publications, rounds of investment, licenses… despite saying goodbye to the EMA and the political instability of this last quarter of the year, the Catalan healthcare and life sciences sector has maintained its role as a global benchmark for this type of ecosystem.